MinorityHeartHealth.org
  • Home
  • About Us
  • Issues
    • Quality Measures
    • Veterans
    • 1,000,000 Hearts Initiative
    • Hospital Adherence
  • Facts and FIndings
    • The Data
    • The Evidence
    • Patient Access Study
    • NQF Quality Measure
  • Blog
  • Get Involved
    • Voices for Change
    • Join Us

Facts and FIndings

The Data

Heart failure has become a major public health issue affecting millions of Americans. A person’s race or ethnicity should not put them more at risk for having heart failure - but unfortunately, it does. African Americans are more at risk for heart failure than any other race or ethnic group. But fortunately, a proven treatment exists.  

Heart Failure is a Growing Health Concern
  • About 5.1 million people in the United States are living with heart failure
  • An estimated 400,000 to 700,000 new cases of heart failure are diagnosed each year
  • The number of deaths in in the United States from heart failure has more than doubled since 1979, averaging 250,000 annually
  • About half of people who develop heart failure die within 5 years of diagnosis
 
Heart Failure has a Unique, Disparate Impact on African Americans
  • Heart failure is associated with higher rates of hospitalization and mortality in the African-American population than among whites
  • African Americans tend to acquire heart failure at an earlier age with more advanced heart damage
  • African-Americans under the age of 50 have a 20% higher prevalence of heart failure compared to whites under the age of 50
  • African American men are 30% more likely to die from heart disease than non-Hispanic white men
 
Innovative Therapy for African Americans with Heart Failure is Available
  • According to a study in the New England Journal of Medicine, fixed dose ID/H reduced mortality for African American patients with heart failure by 43%
  • According to a study in the New England Journal of Medicine, fixed dose ID/H also showed a 39% reduction in first time heart failure-related hospitalization and a substantial improvement in patient-reported quality of life factors
 
Access to Recommended Therapy is Limited, Contributing to Ongoing Disparities
  • Despite the strong clinical evidence, only 22% of eligible heart failure patients receive fixed dose ID/H or either of its components upon discharge from a heart failure-related hospital admission
  • In spite of Class 1A recommendation, less than 10% of eligible patients on Medicare Part D are receiving ID/H therapy
Powered by Create your own unique website with customizable templates.
  • Home
  • About Us
  • Issues
    • Quality Measures
    • Veterans
    • 1,000,000 Hearts Initiative
    • Hospital Adherence
  • Facts and FIndings
    • The Data
    • The Evidence
    • Patient Access Study
    • NQF Quality Measure
  • Blog
  • Get Involved
    • Voices for Change
    • Join Us